LEASE AGREEMENTLease Agreement • July 27th, 2015 • NantKwest, Inc. • Biological products, (no disgnostic substances)
THIS LEASE AGREEMENT (this “Lease”) is made this 19th day of June, 2015, between ARE-JOHN HOPKINS COURT, LLC, a Delaware limited liability company (“Landlord”), and CONKWEST, INC., a Delaware corporation (“Tenant”).
LICENSE AGREEMENT BETWEEN ZELLERX CORPORATION AND HANS G. KLINGEMANNLicense Agreement • July 27th, 2015 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Illinois
This License Agreement (“Agreement”), dated as of February 10, 2003, between Hans G. Klingemann, an individual (“Klingemann”), and ZelleRx Corporation, an Illinois corporation (“ZelleRx”).
JOINT DEVELOPMENT AND LICENSE AGREEMENTJoint Development and License Agreement • July 27th, 2015 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Delaware
This Joint Development and License Agreement (this “Agreement”) is made and entered into as of the 18th day of December, 2014 (the “Effective Date”), by and between CONKWEST INCORPORATED, a Delaware corporation with offices at 2533 South Coast Highway 101, Suite 210, Cardiff-By-The-Sea, CA 92007-2133 (“CONKWEST”), and SORRENTO THERAPEUTICS, INC., a Delaware corporation with offices at 6042 Cornerstone Ct. W., San Diego, Ca 92121 (“SRNE”). CONKWEST and SRNE are sometimes referred to herein individually as a “Party” and together as the “Parties.”
LICENSE AGREEMENT BETWEEN ZELLERX CORPORATION AND FOX CHASE CANCER CENTERLicense Agreement • July 27th, 2015 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Illinois
This License Agreement (“Agreement”), dated as of July 10, 2004, between Fox Chase Cancer Center, a not for profit institution (“Fox Chase”), and ZelleRx Corporation, an Illinois corporation (“ZelleRx”).
RUSH- ZELLERX LICENSE AGREEMENTConfidential Treatment • July 27th, 2015 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Illinois
This License Agreement (“Agreement”), dated March 24, 2004, between Rush University Medical Center, an Illinois not-for-profit corporation (“RUSH”), and ZelleRx, an Illinois for profit corporation (“LICENSEE”).
